Journal of Infection
Volume 59, Supplement 1 , Pages S75-S80, September 2009

Future gazing in the management of multiply drug-resistant Gram-positive infection

  • Mark H. Wilcox

      Affiliations

    • Corresponding Author InformationCorrespondence: Prof. M.H. Wilcox, Microbiology, Old Medical School, Leeds General Infirmary & University of Leeds, Leeds LS1 3EX, UK. Tel.: +44 113 3926818; fax: +44 113 3435649

Department of Microbiology, Leeds Teaching Hospitals NHS Trust and Institute of Molecular and Cellular Biology, University of Leeds, Leeds, UK

Summary 

Gram-positive bacteria have evolved to become predominant health care associated pathogens. To meet this challenge, novel approaches to the development, prescribing, and control of antibiotics will be needed. Additional infection control methods must also be explored. This review discusses the challenges posed in particular by methicillin-resistant staphylococci and potential ways forward.

Keywords:  Antimicrobial selection , Multidrug resistance , Gram-positive bacteria , Guidelines , Linezolid , MRSA

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0163-4453(09)60010-4

doi:10.1016/S0163-4453(09)60010-4

Journal of Infection
Volume 59, Supplement 1 , Pages S75-S80, September 2009

Article Tools